Should You Invest in Ozempic Maker Novo Nordisk in 2026?

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

Ozempic, Wegovy users’ grocery bills shrinking along with their waistlines, new study shows

Households that start taking blockbuster GLP-1 appetite suppressants like Ozempic and Wegovy slash food spending within ...

Is Ozempic safe for weight loss? What doctors want you to know

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...
Stacker on MSN

Are Ozempic and Wegovy knock-offs safe? What to know about compounded GLP-1s

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

Ozempic Is Shrinking More Than Waistlines, It’s Slashing Americans’ Food Bills

As GLP-1 weight-loss drugs become more common, their effects may be reshaping everyday food choices in ways that extend far beyond individual health. When people in the United States begin using ...

Wegovy Pill Will Be Available Early Next Year

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...

GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: With the Semaglutide Patent Expiring in 2026 Onwards, the Biosimilars Market is Expecte…

The GLP-1 agonists market is set to skyrocket, reaching USD 170.75 billion by 2033, growing from USD 64.42 billion in 2025 at ...